Imunon, Inc.
IMNN· Nasdaq
Filed Mar 27, 2018 · 10-K · 86 days after period end · 0001437749-18-005539
derived · Computed from the longer spans the company filed.
| Metric | Q4 2017dderived from reported figures | Q4 2016dderived from reported figures | Q4 2015 | Q4 2014 |
|---|---|---|---|---|
| Revenue | $125.00K | — | $125.00K | $125.00K |
| Net Income | -$3.90M | -$5.40M | -$5.51M | -$6.46M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Imunon, Inc. · CIK 749647 · Engraved from SEC EDGAR
ended Dec 31, 2017 · filed Mar 27, 2018 · 86 d after period end